SUBSCRIBE
SUBSCRIBE

Nick Paul Taylor

Nick is a freelance writer who has been reporting on the global life sciences industry since 2008. With a BSc in biology, Nick writes about the science and business of biopharma and medtech for numerous healthcare publications. He can be reached at nick.paul.taylor@gmail.com or on LinkedIn.

Pictured: J&J's office in Madrid, Spain
Manufacturing
J&J Plans $1B Investment in PA Cell Therapy Manufacturing Facility
Once fully operational, the Pennsylvania site will employ more than 500 people and make cell therapies for thousands of patients a year.
February 19, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Water faucet with drop coming out
Manufacturing
Radiopharma Sector Races To Secure Actinium-225 Supply as Pipelines Expand
Suppliers are investing in production to support deals with AstraZeneca, Bayer and other drugmakers that are advancing radioisotope-based cancer therapies.
February 17, 2026
 · 
4 min read
 · 
Nick Paul Taylor
Castillo San Felipe del Morro in San Juan, Puerto Rico
Manufacturing
PharmaEssentia Shores Up Supply With $46M Investment in Puerto Rico Plant
The Taiwan-based company is establishing a manufacturing center for the U.S. market.
February 11, 2026
 · 
2 min read
 · 
Nick Paul Taylor
There is one person missing to complete the team
Recruiting
Facing Talent Crunch, Radiopharma Field Casts a Wide Net
As the field grows rapidly, companies are luring people from other nuclear industries and tapping the expanding educational talent pipeline, but are constrained by a steep learning curve and the value of real-world experience.
February 10, 2026
 · 
4 min read
 · 
Nick Paul Taylor
A teamwork with different purpose. Isolated Vector illustration
Drug Development
BioNTech’s Multi-Modality Play Outpaces Moderna’s mRNA-Focused Pipeline
After advancing in lockstep through the pandemic, the fortunes of the biotechs have diverged as their use of COVID-19 windfalls has taken shape.
February 3, 2026
 · 
5 min read
 · 
Nick Paul Taylor
Businessman pushing boulder uphill vector concept of Sisyphus. Symbol of hard work, futile effort, strength, struggle, challenge but also motivation and ambition. Eps10 vector illustration.
Manufacturing
As Amgen and Lilly Recommit, Puerto Rico Seeks To Regain Manufacturing Momentum
After suffering in the wake of expired tax incentives for pharmas, the island is trying to take advantage of geopolitics to grow its drug manufacturing sector.
February 3, 2026
 · 
4 min read
 · 
Nick Paul Taylor
Welcome to Pennsylvania sign at the Pennsylvania/New York state line along Interstate 90.
Manufacturing
Eli Lilly Commits $3.5B To Build Injectable Obesity Drug Plant in PA
The facility, which is part of Lilly’s $50 billion reshoring drive, will make obesity drugs such as tirzepatide and retatrutide when it starts operations in 2031.
February 2, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Crowdfunding concept with money icon and human hands in retro 80s collage mixed media vector illustration. Idea for financing business project, funding, philanthropy, cooperation, bank credit and startup development.
Manufacturing
BMS-Partnered Cellares Raises $257M for Cell Therapy Manufacturing Expansion
Cellares, which last year became the first company to receive the FDA’s new advanced manufacturing technology designation, expects to support clinical production this year and offer commercial-scale manufacturing services in 2027.
January 28, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Creative sketch collage of business people handshake gesture approval project development success colleagues cooperation support.
Manufacturing
Big Pharma Tight-Lipped on Details of API Stockpile Deals
Bristol Myers Squibb, GSK and Merck are contributing drug ingredients as part of their deals with the White House but are keeping many of the terms of their agreements private.
January 27, 2026
 · 
4 min read
 · 
Nick Paul Taylor
Business and Project Roadmap Concept. Touching on virtual screen with roadmap overlay representing steps in a project or strategic planning process. Waypoint icons and ends with goal achievement.
Manufacturing
FDA Sets Feb. 1 Launch Date for PreCheck Pilot To Strengthen Domestic Supply Chain
The U.S. regulator shared the roadmap for implementing the program, first proposed in August 2025, and teased changes made in response to industry feedback.
January 22, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Dec 3, 2019 South San Francisco / CA / USA - Genentech headquarters in San Francisco Bay Area; Genentech, Inc., is an American biotechnology corporation which became a subsidiary of Roche in 2009
Manufacturing
Roche Raises NC Manufacturing Investment to $2B To Support Obesity Challenge
Genentech, a member of the Roche Group, plans to open the facility in 2029 to ramp up capacity to make obesity candidates, including the dual GLP-1/GIP receptor agonist CT-388.
January 21, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Photo taken in Ting Kok, Hong Kong
Manufacturing
CDMOs Pin Hopes for Accelerating Uptake at New US Sites on FDA’s PreCheck Program
The initiative could tackle the first-mover disadvantage some CDMOs believe deters early customers, but leaders at companies including Novo Nordisk see hurdles to implementing the changes.
January 20, 2026
 · 
4 min read
 · 
Nick Paul Taylor
Corporate headquarters of Novo Nordisk in Denmark
Business
JPM26: Novo Refocuses on Diabetes and Obesity Amid Push To Expand GLP-1 Market
After a period of diversification, Novo Nordisk is returning to its roots by focusing on the 2 billion people with diabetes, obesity or overweight.
January 14, 2026
 · 
3 min read
 · 
Nick Paul Taylor
Pictured: Eli Lilly's headquarters in Indianapolis
Business
JPM26: Lilly Plots Path to Dominance as Obesity Market Enters a New Era
BMO analysts say Eli Lilly is well-positioned to maintain its lead in the ballooning weight loss space, predicting “strengthening leadership in obesity and beyond” as portfolios expand and patient access improves.
January 14, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Johnson & Johnson's business center in Switzerland
Manufacturing
J&J To Add 500 Jobs at New Plant, Doubling Down on North Carolina
Johnson & Johnson’s second facility in Wilson, North Carolina, is part of a $55 billion push to make all advanced medicines used in the U.S. domestically.
January 13, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Load More